Dhanvantri Jeevan Rekha Ltd

AGM Details

• Date and time: 29 September 2026, 03:00 PM to 03:18 PM
• Venue: 1-Saket, Meerut 250001
• Mode: physical; e-voting open for 15 minutes after adjournment

Ordinary Business Resolutions

• Adopt audited standalone financial statements for FY ended 31 March 2026
• Re-appoint Tulsi Prasad Sharma as director, retiring by rotation
• Re-appoint Rowena Sharma as director, retiring by rotation

Director Changes

• Directors re-appointed: Tulsi Prasad Sharma and Rowena Sharma

Financial highlights

• Revenue from operations rose to 2,585.84 Lakhs, up 14.17% YoY.
• Other income 32.93 Lakhs; lower than prior year.
• PAT was 39.07 Lakhs; reserves increased by 38.45 Lakhs transferred.
• PBT stood at 40.00 Lakhs; tax expense 0.92 Lakhs.
• No long-term borrowings; company debt-free.
• Dividends for FY2025-26 were not recommended.
• Basic EPS 0.94; business remains cash-flow positive.

Operations and segment

• Hospital services remain the core business; single reportable segment.
• Operations concentrated in Meerut region; no subsidiaries or JV.
• AGM held via VC/OAVM; e-Voting facility available.
• Workforce of 106 employees as of 31 March 2026.

Capital structure and resources

• Paid-up equity capital Rs 41.54 million; 4,208,800 shares issued.
• Net worth Rs 1,051.56 Lakhs; total equity Rs 1,051.56 Lakhs.
• Reserves Rs 63.62 million; no borrowings; debt-equity not applicable.
• Current assets Rs 640.64 Lakhs; current liabilities Rs 650.44 Lakhs.
• Cash and cash equivalents around Rs 35-37 Lakhs at year-end.

Governance, audits and controls

• Statutory auditor: Anuj Goyal & Co; Secretarial auditor: Sumit Bist & Associates.
• Audit report: no observations; internal controls adequate.
• Board meetings held: 12 during year; committees: Audit, Nomination & Remuneration, Stakeholders.
• Board independence affirmed; CFO/CEO certification on internal controls.

Risks and outlook

• Outlook positive for Indian healthcare; focus on utilisation, quality, and cost control.
• Key risks: rising medical consumables, manpower costs, regulatory changes.
• Risk management framework in place; no separate risk committee per Reg 21.

Related party transactions and CSR

• Related party transactions include sitting fees; director consultancy; arms-length.
• No significant related party conflicts; CSR not applicable under law.

Legal and compliance disclosures

• Code of conduct adopted; CFO/CEO certification on financial reporting.
• Secretarial compliance: directors not disqualified; annual return available on website.

Book closure and AGM details

• Book closure from 23 September 2026 to 29 September 2026 (inclusive) for AGM.
• AGM scheduled for 29 September 2026 at 03:00 PM via video conferencing.
• Cut-off date for remote e-voting fixed at 22 September 2026.
• E-voting period starts 26 September 2026 at 09:00 AM and ends 28 September 2026 at 05:00 PM.
• Security affected: equity shares.

Key resolutions

• AGM scheduled for 29 September 2026 at 3:00 PM via VC/OAVM.
• Approved Board Report for year ending 31 March 2026.
• Book closure 23-29 September 2026; record date 22 September 2025.
• Appointed Mr. Sarat Jain, PCS (Meerut), as AGM Scrutinizer.
• E-voting from 26 September 2025 to 28 September 2025; cut-off 21 September 2025.

Meeting Details

• Board meeting scheduled for 27 August 2026 at 03:00 PM; venue not disclosed.

Key Agenda Items

• To consider calling Annual General Meeting for the year ending 2026.

Other Notes

• Intimation notes that AGM will be called; no further agenda details disclosed.

Board actions

• Board approved unaudited standalone results for quarter ended 30 Jun 2026; results to be published.
• AGM fixed on 28 Sep 2028 at 3:00 PM.

Financial highlights

• Net sales 780 Lakhs; Total income 787 Lakhs; Total expenses 769 Lakhs.
• Profit after tax / total comprehensive income 18 Lakhs; EPS Rs 4.10.

Audit & compliance

• Limited Review by Anuj Goyal & Co; report dated 13 Jul 2026.
• IND AS-compliant; results prepared under Regulation 33 SEBI LODR.
• No complaints pending.

Notes & comparatives

• Previous quarter figures regrouped/recast where necessary.

Meeting Details

• Date and time: 13 August 2026 at 03:00 PM.

Key Agenda Items

• Consider and approve unaudited results for quarter ended 30 June 2026 with Limited Review Report.

Other Notes

• Trading window closed from July 1, 2026 to 48 hours after results are made public.